Global Equine Chorionic Gonadotropin (eCG) for Injection Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
Equine chorionic gonadotropin (eCG), also known as pregnant mare serum gonadotropin (PMSG) or equine luteinizing hormone. Equine chorionic gonadotropin is a gonadotropic hormone produced in the chorion of pregnant mares. The action of eCG is similar to the action of Follicle- Stimulating Hormone (FSH), which is produced by the animals' anterior pituitary gland. It stimulates the follicles of the ovaries to produce mature ova (eggs), and it promotes the outward signs of estrus (heat).
The global Equine Chorionic Gonadotropin (eCG) for Injection market size is projected to grow from US$ 263 million in 2024 to US$ 352 million in 2030; it is expected to grow at a CAGR of 5.0% from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Equine Chorionic Gonadotropin (eCG) for Injection Industry Forecast” looks at past sales and reviews total world Equine Chorionic Gonadotropin (eCG) for Injection sales in 2023, providing a comprehensive analysis by region and market sector of projected Equine Chorionic Gonadotropin (eCG) for Injection sales for 2024 through 2030. With Equine Chorionic Gonadotropin (eCG) for Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Equine Chorionic Gonadotropin (eCG) for Injection industry.
This Insight Report provides a comprehensive analysis of the global Equine Chorionic Gonadotropin (eCG) for Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Equine Chorionic Gonadotropin (eCG) for Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Equine Chorionic Gonadotropin (eCG) for Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Equine Chorionic Gonadotropin (eCG) for Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Equine Chorionic Gonadotropin (eCG) for Injection.
United States market for Equine Chorionic Gonadotropin (eCG) for Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Equine Chorionic Gonadotropin (eCG) for Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Equine Chorionic Gonadotropin (eCG) for Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Equine Chorionic Gonadotropin (eCG) for Injection players cover MSD Animal Health, Ceva Santй Animale, Syntex SA, Bioveta, Ningbo Sansheng Biological Technology, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Equine Chorionic Gonadotropin (eCG) for Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Equine Chorionic Gonadotropin (eCG) for Injection market?
What factors are driving Equine Chorionic Gonadotropin (eCG) for Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Equine Chorionic Gonadotropin (eCG) for Injection market opportunities vary by end market size?
How does Equine Chorionic Gonadotropin (eCG) for Injection break out by Type, by Application?
Equine chorionic gonadotropin (eCG), also known as pregnant mare serum gonadotropin (PMSG) or equine luteinizing hormone. Equine chorionic gonadotropin is a gonadotropic hormone produced in the chorion of pregnant mares. The action of eCG is similar to the action of Follicle- Stimulating Hormone (FSH), which is produced by the animals' anterior pituitary gland. It stimulates the follicles of the ovaries to produce mature ova (eggs), and it promotes the outward signs of estrus (heat).
The global Equine Chorionic Gonadotropin (eCG) for Injection market size is projected to grow from US$ 263 million in 2024 to US$ 352 million in 2030; it is expected to grow at a CAGR of 5.0% from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Equine Chorionic Gonadotropin (eCG) for Injection Industry Forecast” looks at past sales and reviews total world Equine Chorionic Gonadotropin (eCG) for Injection sales in 2023, providing a comprehensive analysis by region and market sector of projected Equine Chorionic Gonadotropin (eCG) for Injection sales for 2024 through 2030. With Equine Chorionic Gonadotropin (eCG) for Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Equine Chorionic Gonadotropin (eCG) for Injection industry.
This Insight Report provides a comprehensive analysis of the global Equine Chorionic Gonadotropin (eCG) for Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Equine Chorionic Gonadotropin (eCG) for Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Equine Chorionic Gonadotropin (eCG) for Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Equine Chorionic Gonadotropin (eCG) for Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Equine Chorionic Gonadotropin (eCG) for Injection.
United States market for Equine Chorionic Gonadotropin (eCG) for Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Equine Chorionic Gonadotropin (eCG) for Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Equine Chorionic Gonadotropin (eCG) for Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Equine Chorionic Gonadotropin (eCG) for Injection players cover MSD Animal Health, Ceva Santй Animale, Syntex SA, Bioveta, Ningbo Sansheng Biological Technology, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Equine Chorionic Gonadotropin (eCG) for Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- 1000 IU/Unit
- 5000 IU/Unit
- Others
- Pig
- Cattle
- Sheep
- Horse
- Other Animals
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- MSD Animal Health
- Ceva Santй Animale
- Syntex SA
- Bioveta
- Ningbo Sansheng Biological Technology
- Ningbo Second Hormone Factory
- Chifeng Bo-en Pharmaceutical
- Guangzhou Vbio-Pharma
- JALLY
- Ningbo Creator Animal Pharmaceutical
What is the 10-year outlook for the global Equine Chorionic Gonadotropin (eCG) for Injection market?
What factors are driving Equine Chorionic Gonadotropin (eCG) for Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Equine Chorionic Gonadotropin (eCG) for Injection market opportunities vary by end market size?
How does Equine Chorionic Gonadotropin (eCG) for Injection break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Equine Chorionic Gonadotropin (eCG) for Injection Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Equine Chorionic Gonadotropin (eCG) for Injection by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Equine Chorionic Gonadotropin (eCG) for Injection by Country/Region, 2019, 2023 & 2030
2.2 Equine Chorionic Gonadotropin (eCG) for Injection Segment by Type
2.2.1 1000 IU/Unit
2.2.2 5000 IU/Unit
2.2.3 Others
2.3 Equine Chorionic Gonadotropin (eCG) for Injection Sales by Type
2.3.1 Global Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Type (2019-2024)
2.3.2 Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue and Market Share by Type (2019-2024)
2.3.3 Global Equine Chorionic Gonadotropin (eCG) for Injection Sale Price by Type (2019-2024)
2.4 Equine Chorionic Gonadotropin (eCG) for Injection Segment by Application
2.4.1 Pig
2.4.2 Cattle
2.4.3 Sheep
2.4.4 Horse
2.4.5 Other Animals
2.5 Equine Chorionic Gonadotropin (eCG) for Injection Sales by Application
2.5.1 Global Equine Chorionic Gonadotropin (eCG) for Injection Sale Market Share by Application (2019-2024)
2.5.2 Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue and Market Share by Application (2019-2024)
2.5.3 Global Equine Chorionic Gonadotropin (eCG) for Injection Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Equine Chorionic Gonadotropin (eCG) for Injection Breakdown Data by Company
3.1.1 Global Equine Chorionic Gonadotropin (eCG) for Injection Annual Sales by Company (2019-2024)
3.1.2 Global Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Company (2019-2024)
3.2 Global Equine Chorionic Gonadotropin (eCG) for Injection Annual Revenue by Company (2019-2024)
3.2.1 Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Company (2019-2024)
3.2.2 Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue Market Share by Company (2019-2024)
3.3 Global Equine Chorionic Gonadotropin (eCG) for Injection Sale Price by Company
3.4 Key Manufacturers Equine Chorionic Gonadotropin (eCG) for Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Equine Chorionic Gonadotropin (eCG) for Injection Product Location Distribution
3.4.2 Players Equine Chorionic Gonadotropin (eCG) for Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR EQUINE CHORIONIC GONADOTROPIN (ECG) FOR INJECTION BY GEOGRAPHIC REGION
4.1 World Historic Equine Chorionic Gonadotropin (eCG) for Injection Market Size by Geographic Region (2019-2024)
4.1.1 Global Equine Chorionic Gonadotropin (eCG) for Injection Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Equine Chorionic Gonadotropin (eCG) for Injection Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Equine Chorionic Gonadotropin (eCG) for Injection Market Size by Country/Region (2019-2024)
4.2.1 Global Equine Chorionic Gonadotropin (eCG) for Injection Annual Sales by Country/Region (2019-2024)
4.2.2 Global Equine Chorionic Gonadotropin (eCG) for Injection Annual Revenue by Country/Region (2019-2024)
4.3 Americas Equine Chorionic Gonadotropin (eCG) for Injection Sales Growth
4.4 APAC Equine Chorionic Gonadotropin (eCG) for Injection Sales Growth
4.5 Europe Equine Chorionic Gonadotropin (eCG) for Injection Sales Growth
4.6 Middle East & Africa Equine Chorionic Gonadotropin (eCG) for Injection Sales Growth
5 AMERICAS
5.1 Americas Equine Chorionic Gonadotropin (eCG) for Injection Sales by Country
5.1.1 Americas Equine Chorionic Gonadotropin (eCG) for Injection Sales by Country (2019-2024)
5.1.2 Americas Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Country (2019-2024)
5.2 Americas Equine Chorionic Gonadotropin (eCG) for Injection Sales by Type (2019-2024)
5.3 Americas Equine Chorionic Gonadotropin (eCG) for Injection Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Equine Chorionic Gonadotropin (eCG) for Injection Sales by Region
6.1.1 APAC Equine Chorionic Gonadotropin (eCG) for Injection Sales by Region (2019-2024)
6.1.2 APAC Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Region (2019-2024)
6.2 APAC Equine Chorionic Gonadotropin (eCG) for Injection Sales by Type (2019-2024)
6.3 APAC Equine Chorionic Gonadotropin (eCG) for Injection Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Equine Chorionic Gonadotropin (eCG) for Injection by Country
7.1.1 Europe Equine Chorionic Gonadotropin (eCG) for Injection Sales by Country (2019-2024)
7.1.2 Europe Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Country (2019-2024)
7.2 Europe Equine Chorionic Gonadotropin (eCG) for Injection Sales by Type (2019-2024)
7.3 Europe Equine Chorionic Gonadotropin (eCG) for Injection Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Equine Chorionic Gonadotropin (eCG) for Injection by Country
8.1.1 Middle East & Africa Equine Chorionic Gonadotropin (eCG) for Injection Sales by Country (2019-2024)
8.1.2 Middle East & Africa Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Country (2019-2024)
8.2 Middle East & Africa Equine Chorionic Gonadotropin (eCG) for Injection Sales by Type (2019-2024)
8.3 Middle East & Africa Equine Chorionic Gonadotropin (eCG) for Injection Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Equine Chorionic Gonadotropin (eCG) for Injection
10.3 Manufacturing Process Analysis of Equine Chorionic Gonadotropin (eCG) for Injection
10.4 Industry Chain Structure of Equine Chorionic Gonadotropin (eCG) for Injection
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Equine Chorionic Gonadotropin (eCG) for Injection Distributors
11.3 Equine Chorionic Gonadotropin (eCG) for Injection Customer
12 WORLD FORECAST REVIEW FOR EQUINE CHORIONIC GONADOTROPIN (ECG) FOR INJECTION BY GEOGRAPHIC REGION
12.1 Global Equine Chorionic Gonadotropin (eCG) for Injection Market Size Forecast by Region
12.1.1 Global Equine Chorionic Gonadotropin (eCG) for Injection Forecast by Region (2025-2030)
12.1.2 Global Equine Chorionic Gonadotropin (eCG) for Injection Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Equine Chorionic Gonadotropin (eCG) for Injection Forecast by Type (2025-2030)
12.7 Global Equine Chorionic Gonadotropin (eCG) for Injection Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 MSD Animal Health
13.1.1 MSD Animal Health Company Information
13.1.2 MSD Animal Health Equine Chorionic Gonadotropin (eCG) for Injection Product Portfolios and Specifications
13.1.3 MSD Animal Health Equine Chorionic Gonadotropin (eCG) for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 MSD Animal Health Main Business Overview
13.1.5 MSD Animal Health Latest Developments
13.2 Ceva Santй Animale
13.2.1 Ceva Santй Animale Company Information
13.2.2 Ceva Santй Animale Equine Chorionic Gonadotropin (eCG) for Injection Product Portfolios and Specifications
13.2.3 Ceva Santй Animale Equine Chorionic Gonadotropin (eCG) for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Ceva Santй Animale Main Business Overview
13.2.5 Ceva Santй Animale Latest Developments
13.3 Syntex SA
13.3.1 Syntex SA Company Information
13.3.2 Syntex SA Equine Chorionic Gonadotropin (eCG) for Injection Product Portfolios and Specifications
13.3.3 Syntex SA Equine Chorionic Gonadotropin (eCG) for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Syntex SA Main Business Overview
13.3.5 Syntex SA Latest Developments
13.4 Bioveta
13.4.1 Bioveta Company Information
13.4.2 Bioveta Equine Chorionic Gonadotropin (eCG) for Injection Product Portfolios and Specifications
13.4.3 Bioveta Equine Chorionic Gonadotropin (eCG) for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Bioveta Main Business Overview
13.4.5 Bioveta Latest Developments
13.5 Ningbo Sansheng Biological Technology
13.5.1 Ningbo Sansheng Biological Technology Company Information
13.5.2 Ningbo Sansheng Biological Technology Equine Chorionic Gonadotropin (eCG) for Injection Product Portfolios and Specifications
13.5.3 Ningbo Sansheng Biological Technology Equine Chorionic Gonadotropin (eCG) for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Ningbo Sansheng Biological Technology Main Business Overview
13.5.5 Ningbo Sansheng Biological Technology Latest Developments
13.6 Ningbo Second Hormone Factory
13.6.1 Ningbo Second Hormone Factory Company Information
13.6.2 Ningbo Second Hormone Factory Equine Chorionic Gonadotropin (eCG) for Injection Product Portfolios and Specifications
13.6.3 Ningbo Second Hormone Factory Equine Chorionic Gonadotropin (eCG) for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Ningbo Second Hormone Factory Main Business Overview
13.6.5 Ningbo Second Hormone Factory Latest Developments
13.7 Chifeng Bo-en Pharmaceutical
13.7.1 Chifeng Bo-en Pharmaceutical Company Information
13.7.2 Chifeng Bo-en Pharmaceutical Equine Chorionic Gonadotropin (eCG) for Injection Product Portfolios and Specifications
13.7.3 Chifeng Bo-en Pharmaceutical Equine Chorionic Gonadotropin (eCG) for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Chifeng Bo-en Pharmaceutical Main Business Overview
13.7.5 Chifeng Bo-en Pharmaceutical Latest Developments
13.8 Guangzhou Vbio-Pharma
13.8.1 Guangzhou Vbio-Pharma Company Information
13.8.2 Guangzhou Vbio-Pharma Equine Chorionic Gonadotropin (eCG) for Injection Product Portfolios and Specifications
13.8.3 Guangzhou Vbio-Pharma Equine Chorionic Gonadotropin (eCG) for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Guangzhou Vbio-Pharma Main Business Overview
13.8.5 Guangzhou Vbio-Pharma Latest Developments
13.9 JALLY
13.9.1 JALLY Company Information
13.9.2 JALLY Equine Chorionic Gonadotropin (eCG) for Injection Product Portfolios and Specifications
13.9.3 JALLY Equine Chorionic Gonadotropin (eCG) for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 JALLY Main Business Overview
13.9.5 JALLY Latest Developments
13.10 Ningbo Creator Animal Pharmaceutical
13.10.1 Ningbo Creator Animal Pharmaceutical Company Information
13.10.2 Ningbo Creator Animal Pharmaceutical Equine Chorionic Gonadotropin (eCG) for Injection Product Portfolios and Specifications
13.10.3 Ningbo Creator Animal Pharmaceutical Equine Chorionic Gonadotropin (eCG) for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Ningbo Creator Animal Pharmaceutical Main Business Overview
13.10.5 Ningbo Creator Animal Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Equine Chorionic Gonadotropin (eCG) for Injection Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Equine Chorionic Gonadotropin (eCG) for Injection by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Equine Chorionic Gonadotropin (eCG) for Injection by Country/Region, 2019, 2023 & 2030
2.2 Equine Chorionic Gonadotropin (eCG) for Injection Segment by Type
2.2.1 1000 IU/Unit
2.2.2 5000 IU/Unit
2.2.3 Others
2.3 Equine Chorionic Gonadotropin (eCG) for Injection Sales by Type
2.3.1 Global Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Type (2019-2024)
2.3.2 Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue and Market Share by Type (2019-2024)
2.3.3 Global Equine Chorionic Gonadotropin (eCG) for Injection Sale Price by Type (2019-2024)
2.4 Equine Chorionic Gonadotropin (eCG) for Injection Segment by Application
2.4.1 Pig
2.4.2 Cattle
2.4.3 Sheep
2.4.4 Horse
2.4.5 Other Animals
2.5 Equine Chorionic Gonadotropin (eCG) for Injection Sales by Application
2.5.1 Global Equine Chorionic Gonadotropin (eCG) for Injection Sale Market Share by Application (2019-2024)
2.5.2 Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue and Market Share by Application (2019-2024)
2.5.3 Global Equine Chorionic Gonadotropin (eCG) for Injection Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Equine Chorionic Gonadotropin (eCG) for Injection Breakdown Data by Company
3.1.1 Global Equine Chorionic Gonadotropin (eCG) for Injection Annual Sales by Company (2019-2024)
3.1.2 Global Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Company (2019-2024)
3.2 Global Equine Chorionic Gonadotropin (eCG) for Injection Annual Revenue by Company (2019-2024)
3.2.1 Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Company (2019-2024)
3.2.2 Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue Market Share by Company (2019-2024)
3.3 Global Equine Chorionic Gonadotropin (eCG) for Injection Sale Price by Company
3.4 Key Manufacturers Equine Chorionic Gonadotropin (eCG) for Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Equine Chorionic Gonadotropin (eCG) for Injection Product Location Distribution
3.4.2 Players Equine Chorionic Gonadotropin (eCG) for Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR EQUINE CHORIONIC GONADOTROPIN (ECG) FOR INJECTION BY GEOGRAPHIC REGION
4.1 World Historic Equine Chorionic Gonadotropin (eCG) for Injection Market Size by Geographic Region (2019-2024)
4.1.1 Global Equine Chorionic Gonadotropin (eCG) for Injection Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Equine Chorionic Gonadotropin (eCG) for Injection Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Equine Chorionic Gonadotropin (eCG) for Injection Market Size by Country/Region (2019-2024)
4.2.1 Global Equine Chorionic Gonadotropin (eCG) for Injection Annual Sales by Country/Region (2019-2024)
4.2.2 Global Equine Chorionic Gonadotropin (eCG) for Injection Annual Revenue by Country/Region (2019-2024)
4.3 Americas Equine Chorionic Gonadotropin (eCG) for Injection Sales Growth
4.4 APAC Equine Chorionic Gonadotropin (eCG) for Injection Sales Growth
4.5 Europe Equine Chorionic Gonadotropin (eCG) for Injection Sales Growth
4.6 Middle East & Africa Equine Chorionic Gonadotropin (eCG) for Injection Sales Growth
5 AMERICAS
5.1 Americas Equine Chorionic Gonadotropin (eCG) for Injection Sales by Country
5.1.1 Americas Equine Chorionic Gonadotropin (eCG) for Injection Sales by Country (2019-2024)
5.1.2 Americas Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Country (2019-2024)
5.2 Americas Equine Chorionic Gonadotropin (eCG) for Injection Sales by Type (2019-2024)
5.3 Americas Equine Chorionic Gonadotropin (eCG) for Injection Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Equine Chorionic Gonadotropin (eCG) for Injection Sales by Region
6.1.1 APAC Equine Chorionic Gonadotropin (eCG) for Injection Sales by Region (2019-2024)
6.1.2 APAC Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Region (2019-2024)
6.2 APAC Equine Chorionic Gonadotropin (eCG) for Injection Sales by Type (2019-2024)
6.3 APAC Equine Chorionic Gonadotropin (eCG) for Injection Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Equine Chorionic Gonadotropin (eCG) for Injection by Country
7.1.1 Europe Equine Chorionic Gonadotropin (eCG) for Injection Sales by Country (2019-2024)
7.1.2 Europe Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Country (2019-2024)
7.2 Europe Equine Chorionic Gonadotropin (eCG) for Injection Sales by Type (2019-2024)
7.3 Europe Equine Chorionic Gonadotropin (eCG) for Injection Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Equine Chorionic Gonadotropin (eCG) for Injection by Country
8.1.1 Middle East & Africa Equine Chorionic Gonadotropin (eCG) for Injection Sales by Country (2019-2024)
8.1.2 Middle East & Africa Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Country (2019-2024)
8.2 Middle East & Africa Equine Chorionic Gonadotropin (eCG) for Injection Sales by Type (2019-2024)
8.3 Middle East & Africa Equine Chorionic Gonadotropin (eCG) for Injection Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Equine Chorionic Gonadotropin (eCG) for Injection
10.3 Manufacturing Process Analysis of Equine Chorionic Gonadotropin (eCG) for Injection
10.4 Industry Chain Structure of Equine Chorionic Gonadotropin (eCG) for Injection
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Equine Chorionic Gonadotropin (eCG) for Injection Distributors
11.3 Equine Chorionic Gonadotropin (eCG) for Injection Customer
12 WORLD FORECAST REVIEW FOR EQUINE CHORIONIC GONADOTROPIN (ECG) FOR INJECTION BY GEOGRAPHIC REGION
12.1 Global Equine Chorionic Gonadotropin (eCG) for Injection Market Size Forecast by Region
12.1.1 Global Equine Chorionic Gonadotropin (eCG) for Injection Forecast by Region (2025-2030)
12.1.2 Global Equine Chorionic Gonadotropin (eCG) for Injection Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Equine Chorionic Gonadotropin (eCG) for Injection Forecast by Type (2025-2030)
12.7 Global Equine Chorionic Gonadotropin (eCG) for Injection Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 MSD Animal Health
13.1.1 MSD Animal Health Company Information
13.1.2 MSD Animal Health Equine Chorionic Gonadotropin (eCG) for Injection Product Portfolios and Specifications
13.1.3 MSD Animal Health Equine Chorionic Gonadotropin (eCG) for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 MSD Animal Health Main Business Overview
13.1.5 MSD Animal Health Latest Developments
13.2 Ceva Santй Animale
13.2.1 Ceva Santй Animale Company Information
13.2.2 Ceva Santй Animale Equine Chorionic Gonadotropin (eCG) for Injection Product Portfolios and Specifications
13.2.3 Ceva Santй Animale Equine Chorionic Gonadotropin (eCG) for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Ceva Santй Animale Main Business Overview
13.2.5 Ceva Santй Animale Latest Developments
13.3 Syntex SA
13.3.1 Syntex SA Company Information
13.3.2 Syntex SA Equine Chorionic Gonadotropin (eCG) for Injection Product Portfolios and Specifications
13.3.3 Syntex SA Equine Chorionic Gonadotropin (eCG) for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Syntex SA Main Business Overview
13.3.5 Syntex SA Latest Developments
13.4 Bioveta
13.4.1 Bioveta Company Information
13.4.2 Bioveta Equine Chorionic Gonadotropin (eCG) for Injection Product Portfolios and Specifications
13.4.3 Bioveta Equine Chorionic Gonadotropin (eCG) for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Bioveta Main Business Overview
13.4.5 Bioveta Latest Developments
13.5 Ningbo Sansheng Biological Technology
13.5.1 Ningbo Sansheng Biological Technology Company Information
13.5.2 Ningbo Sansheng Biological Technology Equine Chorionic Gonadotropin (eCG) for Injection Product Portfolios and Specifications
13.5.3 Ningbo Sansheng Biological Technology Equine Chorionic Gonadotropin (eCG) for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Ningbo Sansheng Biological Technology Main Business Overview
13.5.5 Ningbo Sansheng Biological Technology Latest Developments
13.6 Ningbo Second Hormone Factory
13.6.1 Ningbo Second Hormone Factory Company Information
13.6.2 Ningbo Second Hormone Factory Equine Chorionic Gonadotropin (eCG) for Injection Product Portfolios and Specifications
13.6.3 Ningbo Second Hormone Factory Equine Chorionic Gonadotropin (eCG) for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Ningbo Second Hormone Factory Main Business Overview
13.6.5 Ningbo Second Hormone Factory Latest Developments
13.7 Chifeng Bo-en Pharmaceutical
13.7.1 Chifeng Bo-en Pharmaceutical Company Information
13.7.2 Chifeng Bo-en Pharmaceutical Equine Chorionic Gonadotropin (eCG) for Injection Product Portfolios and Specifications
13.7.3 Chifeng Bo-en Pharmaceutical Equine Chorionic Gonadotropin (eCG) for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Chifeng Bo-en Pharmaceutical Main Business Overview
13.7.5 Chifeng Bo-en Pharmaceutical Latest Developments
13.8 Guangzhou Vbio-Pharma
13.8.1 Guangzhou Vbio-Pharma Company Information
13.8.2 Guangzhou Vbio-Pharma Equine Chorionic Gonadotropin (eCG) for Injection Product Portfolios and Specifications
13.8.3 Guangzhou Vbio-Pharma Equine Chorionic Gonadotropin (eCG) for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Guangzhou Vbio-Pharma Main Business Overview
13.8.5 Guangzhou Vbio-Pharma Latest Developments
13.9 JALLY
13.9.1 JALLY Company Information
13.9.2 JALLY Equine Chorionic Gonadotropin (eCG) for Injection Product Portfolios and Specifications
13.9.3 JALLY Equine Chorionic Gonadotropin (eCG) for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 JALLY Main Business Overview
13.9.5 JALLY Latest Developments
13.10 Ningbo Creator Animal Pharmaceutical
13.10.1 Ningbo Creator Animal Pharmaceutical Company Information
13.10.2 Ningbo Creator Animal Pharmaceutical Equine Chorionic Gonadotropin (eCG) for Injection Product Portfolios and Specifications
13.10.3 Ningbo Creator Animal Pharmaceutical Equine Chorionic Gonadotropin (eCG) for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Ningbo Creator Animal Pharmaceutical Main Business Overview
13.10.5 Ningbo Creator Animal Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Equine Chorionic Gonadotropin (eCG) for Injection Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Equine Chorionic Gonadotropin (eCG) for Injection Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of 1000 IU/Unit
Table 4. Major Players of 5000 IU/Unit
Table 5. Major Players of Others
Table 6. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales by Type (2019-2024) & (K Units)
Table 7. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Type (2019-2024)
Table 8. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Type (2019-2024) & ($ million)
Table 9. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue Market Share by Type (2019-2024)
Table 10. Global Equine Chorionic Gonadotropin (eCG) for Injection Sale Price by Type (2019-2024) & (US$/Unit)
Table 11. Global Equine Chorionic Gonadotropin (eCG) for Injection Sale by Application (2019-2024) & (K Units)
Table 12. Global Equine Chorionic Gonadotropin (eCG) for Injection Sale Market Share by Application (2019-2024)
Table 13. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Application (2019-2024) & ($ million)
Table 14. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue Market Share by Application (2019-2024)
Table 15. Global Equine Chorionic Gonadotropin (eCG) for Injection Sale Price by Application (2019-2024) & (US$/Unit)
Table 16. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales by Company (2019-2024) & (K Units)
Table 17. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Company (2019-2024)
Table 18. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Company (2019-2024) & ($ millions)
Table 19. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue Market Share by Company (2019-2024)
Table 20. Global Equine Chorionic Gonadotropin (eCG) for Injection Sale Price by Company (2019-2024) & (US$/Unit)
Table 21. Key Manufacturers Equine Chorionic Gonadotropin (eCG) for Injection Producing Area Distribution and Sales Area
Table 22. Players Equine Chorionic Gonadotropin (eCG) for Injection Products Offered
Table 23. Equine Chorionic Gonadotropin (eCG) for Injection Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales by Geographic Region (2019-2024) & (K Units)
Table 27. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share Geographic Region (2019-2024)
Table 28. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales by Country/Region (2019-2024) & (K Units)
Table 31. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Country/Region (2019-2024)
Table 32. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas Equine Chorionic Gonadotropin (eCG) for Injection Sales by Country (2019-2024) & (K Units)
Table 35. Americas Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Country (2019-2024)
Table 36. Americas Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Country (2019-2024) & ($ millions)
Table 37. Americas Equine Chorionic Gonadotropin (eCG) for Injection Sales by Type (2019-2024) & (K Units)
Table 38. Americas Equine Chorionic Gonadotropin (eCG) for Injection Sales by Application (2019-2024) & (K Units)
Table 39. APAC Equine Chorionic Gonadotropin (eCG) for Injection Sales by Region (2019-2024) & (K Units)
Table 40. APAC Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Region (2019-2024)
Table 41. APAC Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Region (2019-2024) & ($ millions)
Table 42. APAC Equine Chorionic Gonadotropin (eCG) for Injection Sales by Type (2019-2024) & (K Units)
Table 43. APAC Equine Chorionic Gonadotropin (eCG) for Injection Sales by Application (2019-2024) & (K Units)
Table 44. Europe Equine Chorionic Gonadotropin (eCG) for Injection Sales by Country (2019-2024) & (K Units)
Table 45. Europe Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Country (2019-2024) & ($ millions)
Table 46. Europe Equine Chorionic Gonadotropin (eCG) for Injection Sales by Type (2019-2024) & (K Units)
Table 47. Europe Equine Chorionic Gonadotropin (eCG) for Injection Sales by Application (2019-2024) & (K Units)
Table 48. Middle East & Africa Equine Chorionic Gonadotropin (eCG) for Injection Sales by Country (2019-2024) & (K Units)
Table 49. Middle East & Africa Equine Chorionic Gonadotropin (eCG) for Injection Revenue Market Share by Country (2019-2024)
Table 50. Middle East & Africa Equine Chorionic Gonadotropin (eCG) for Injection Sales by Type (2019-2024) & (K Units)
Table 51. Middle East & Africa Equine Chorionic Gonadotropin (eCG) for Injection Sales by Application (2019-2024) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Equine Chorionic Gonadotropin (eCG) for Injection
Table 53. Key Market Challenges & Risks of Equine Chorionic Gonadotropin (eCG) for Injection
Table 54. Key Industry Trends of Equine Chorionic Gonadotropin (eCG) for Injection
Table 55. Equine Chorionic Gonadotropin (eCG) for Injection Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Equine Chorionic Gonadotropin (eCG) for Injection Distributors List
Table 58. Equine Chorionic Gonadotropin (eCG) for Injection Customer List
Table 59. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales Forecast by Region (2025-2030) & (K Units)
Table 60. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue Forecast by Region (2025-2030) & ($ millions)
Table 61. Americas Equine Chorionic Gonadotropin (eCG) for Injection Sales Forecast by Country (2025-2030) & (K Units)
Table 62. Americas Equine Chorionic Gonadotropin (eCG) for Injection Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 63. APAC Equine Chorionic Gonadotropin (eCG) for Injection Sales Forecast by Region (2025-2030) & (K Units)
Table 64. APAC Equine Chorionic Gonadotropin (eCG) for Injection Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 65. Europe Equine Chorionic Gonadotropin (eCG) for Injection Sales Forecast by Country (2025-2030) & (K Units)
Table 66. Europe Equine Chorionic Gonadotropin (eCG) for Injection Revenue Forecast by Country (2025-2030) & ($ millions)
Table 67. Middle East & Africa Equine Chorionic Gonadotropin (eCG) for Injection Sales Forecast by Country (2025-2030) & (K Units)
Table 68. Middle East & Africa Equine Chorionic Gonadotropin (eCG) for Injection Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales Forecast by Type (2025-2030) & (K Units)
Table 70. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue Forecast by Type (2025-2030) & ($ millions)
Table 71. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales Forecast by Application (2025-2030) & (K Units)
Table 72. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue Forecast by Application (2025-2030) & ($ millions)
Table 73. MSD Animal Health Basic Information, Equine Chorionic Gonadotropin (eCG) for Injection Manufacturing Base, Sales Area and Its Competitors
Table 74. MSD Animal Health Equine Chorionic Gonadotropin (eCG) for Injection Product Portfolios and Specifications
Table 75. MSD Animal Health Equine Chorionic Gonadotropin (eCG) for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 76. MSD Animal Health Main Business
Table 77. MSD Animal Health Latest Developments
Table 78. Ceva Santй Animale Basic Information, Equine Chorionic Gonadotropin (eCG) for Injection Manufacturing Base, Sales Area and Its Competitors
Table 79. Ceva Santй Animale Equine Chorionic Gonadotropin (eCG) for Injection Product Portfolios and Specifications
Table 80. Ceva Santй Animale Equine Chorionic Gonadotropin (eCG) for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 81. Ceva Santй Animale Main Business
Table 82. Ceva Santй Animale Latest Developments
Table 83. Syntex SA Basic Information, Equine Chorionic Gonadotropin (eCG) for Injection Manufacturing Base, Sales Area and Its Competitors
Table 84. Syntex SA Equine Chorionic Gonadotropin (eCG) for Injection Product Portfolios and Specifications
Table 85. Syntex SA Equine Chorionic Gonadotropin (eCG) for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 86. Syntex SA Main Business
Table 87. Syntex SA Latest Developments
Table 88. Bioveta Basic Information, Equine Chorionic Gonadotropin (eCG) for Injection Manufacturing Base, Sales Area and Its Competitors
Table 89. Bioveta Equine Chorionic Gonadotropin (eCG) for Injection Product Portfolios and Specifications
Table 90. Bioveta Equine Chorionic Gonadotropin (eCG) for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 91. Bioveta Main Business
Table 92. Bioveta Latest Developments
Table 93. Ningbo Sansheng Biological Technology Basic Information, Equine Chorionic Gonadotropin (eCG) for Injection Manufacturing Base, Sales Area and Its Competitors
Table 94. Ningbo Sansheng Biological Technology Equine Chorionic Gonadotropin (eCG) for Injection Product Portfolios and Specifications
Table 95. Ningbo Sansheng Biological Technology Equine Chorionic Gonadotropin (eCG) for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 96. Ningbo Sansheng Biological Technology Main Business
Table 97. Ningbo Sansheng Biological Technology Latest Developments
Table 98. Ningbo Second Hormone Factory Basic Information, Equine Chorionic Gonadotropin (eCG) for Injection Manufacturing Base, Sales Area and Its Competitors
Table 99. Ningbo Second Hormone Factory Equine Chorionic Gonadotropin (eCG) for Injection Product Portfolios and Specifications
Table 100. Ningbo Second Hormone Factory Equine Chorionic Gonadotropin (eCG) for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 101. Ningbo Second Hormone Factory Main Business
Table 102. Ningbo Second Hormone Factory Latest Developments
Table 103. Chifeng Bo-en Pharmaceutical Basic Information, Equine Chorionic Gonadotropin (eCG) for Injection Manufacturing Base, Sales Area and Its Competitors
Table 104. Chifeng Bo-en Pharmaceutical Equine Chorionic Gonadotropin (eCG) for Injection Product Portfolios and Specifications
Table 105. Chifeng Bo-en Pharmaceutical Equine Chorionic Gonadotropin (eCG) for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 106. Chifeng Bo-en Pharmaceutical Main Business
Table 107. Chifeng Bo-en Pharmaceutical Latest Developments
Table 108. Guangzhou Vbio-Pharma Basic Information, Equine Chorionic Gonadotropin (eCG) for Injection Manufacturing Base, Sales Area and Its Competitors
Table 109. Guangzhou Vbio-Pharma Equine Chorionic Gonadotropin (eCG) for Injection Product Portfolios and Specifications
Table 110. Guangzhou Vbio-Pharma Equine Chorionic Gonadotropin (eCG) for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 111. Guangzhou Vbio-Pharma Main Business
Table 112. Guangzhou Vbio-Pharma Latest Developments
Table 113. JALLY Basic Information, Equine Chorionic Gonadotropin (eCG) for Injection Manufacturing Base, Sales Area and Its Competitors
Table 114. JALLY Equine Chorionic Gonadotropin (eCG) for Injection Product Portfolios and Specifications
Table 115. JALLY Equine Chorionic Gonadotropin (eCG) for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 116. JALLY Main Business
Table 117. JALLY Latest Developments
Table 118. Ningbo Creator Animal Pharmaceutical Basic Information, Equine Chorionic Gonadotropin (eCG) for Injection Manufacturing Base, Sales Area and Its Competitors
Table 119. Ningbo Creator Animal Pharmaceutical Equine Chorionic Gonadotropin (eCG) for Injection Product Portfolios and Specifications
Table 120. Ningbo Creator Animal Pharmaceutical Equine Chorionic Gonadotropin (eCG) for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 121. Ningbo Creator Animal Pharmaceutical Main Business
Table 122. Ningbo Creator Animal Pharmaceutical Latest Developments
Table 1. Equine Chorionic Gonadotropin (eCG) for Injection Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Equine Chorionic Gonadotropin (eCG) for Injection Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of 1000 IU/Unit
Table 4. Major Players of 5000 IU/Unit
Table 5. Major Players of Others
Table 6. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales by Type (2019-2024) & (K Units)
Table 7. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Type (2019-2024)
Table 8. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Type (2019-2024) & ($ million)
Table 9. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue Market Share by Type (2019-2024)
Table 10. Global Equine Chorionic Gonadotropin (eCG) for Injection Sale Price by Type (2019-2024) & (US$/Unit)
Table 11. Global Equine Chorionic Gonadotropin (eCG) for Injection Sale by Application (2019-2024) & (K Units)
Table 12. Global Equine Chorionic Gonadotropin (eCG) for Injection Sale Market Share by Application (2019-2024)
Table 13. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Application (2019-2024) & ($ million)
Table 14. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue Market Share by Application (2019-2024)
Table 15. Global Equine Chorionic Gonadotropin (eCG) for Injection Sale Price by Application (2019-2024) & (US$/Unit)
Table 16. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales by Company (2019-2024) & (K Units)
Table 17. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Company (2019-2024)
Table 18. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Company (2019-2024) & ($ millions)
Table 19. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue Market Share by Company (2019-2024)
Table 20. Global Equine Chorionic Gonadotropin (eCG) for Injection Sale Price by Company (2019-2024) & (US$/Unit)
Table 21. Key Manufacturers Equine Chorionic Gonadotropin (eCG) for Injection Producing Area Distribution and Sales Area
Table 22. Players Equine Chorionic Gonadotropin (eCG) for Injection Products Offered
Table 23. Equine Chorionic Gonadotropin (eCG) for Injection Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales by Geographic Region (2019-2024) & (K Units)
Table 27. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share Geographic Region (2019-2024)
Table 28. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Geographic Region (2019-2024) & ($ millions)
Table 29. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue Market Share by Geographic Region (2019-2024)
Table 30. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales by Country/Region (2019-2024) & (K Units)
Table 31. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Country/Region (2019-2024)
Table 32. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Country/Region (2019-2024) & ($ millions)
Table 33. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue Market Share by Country/Region (2019-2024)
Table 34. Americas Equine Chorionic Gonadotropin (eCG) for Injection Sales by Country (2019-2024) & (K Units)
Table 35. Americas Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Country (2019-2024)
Table 36. Americas Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Country (2019-2024) & ($ millions)
Table 37. Americas Equine Chorionic Gonadotropin (eCG) for Injection Sales by Type (2019-2024) & (K Units)
Table 38. Americas Equine Chorionic Gonadotropin (eCG) for Injection Sales by Application (2019-2024) & (K Units)
Table 39. APAC Equine Chorionic Gonadotropin (eCG) for Injection Sales by Region (2019-2024) & (K Units)
Table 40. APAC Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Region (2019-2024)
Table 41. APAC Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Region (2019-2024) & ($ millions)
Table 42. APAC Equine Chorionic Gonadotropin (eCG) for Injection Sales by Type (2019-2024) & (K Units)
Table 43. APAC Equine Chorionic Gonadotropin (eCG) for Injection Sales by Application (2019-2024) & (K Units)
Table 44. Europe Equine Chorionic Gonadotropin (eCG) for Injection Sales by Country (2019-2024) & (K Units)
Table 45. Europe Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Country (2019-2024) & ($ millions)
Table 46. Europe Equine Chorionic Gonadotropin (eCG) for Injection Sales by Type (2019-2024) & (K Units)
Table 47. Europe Equine Chorionic Gonadotropin (eCG) for Injection Sales by Application (2019-2024) & (K Units)
Table 48. Middle East & Africa Equine Chorionic Gonadotropin (eCG) for Injection Sales by Country (2019-2024) & (K Units)
Table 49. Middle East & Africa Equine Chorionic Gonadotropin (eCG) for Injection Revenue Market Share by Country (2019-2024)
Table 50. Middle East & Africa Equine Chorionic Gonadotropin (eCG) for Injection Sales by Type (2019-2024) & (K Units)
Table 51. Middle East & Africa Equine Chorionic Gonadotropin (eCG) for Injection Sales by Application (2019-2024) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Equine Chorionic Gonadotropin (eCG) for Injection
Table 53. Key Market Challenges & Risks of Equine Chorionic Gonadotropin (eCG) for Injection
Table 54. Key Industry Trends of Equine Chorionic Gonadotropin (eCG) for Injection
Table 55. Equine Chorionic Gonadotropin (eCG) for Injection Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Equine Chorionic Gonadotropin (eCG) for Injection Distributors List
Table 58. Equine Chorionic Gonadotropin (eCG) for Injection Customer List
Table 59. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales Forecast by Region (2025-2030) & (K Units)
Table 60. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue Forecast by Region (2025-2030) & ($ millions)
Table 61. Americas Equine Chorionic Gonadotropin (eCG) for Injection Sales Forecast by Country (2025-2030) & (K Units)
Table 62. Americas Equine Chorionic Gonadotropin (eCG) for Injection Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 63. APAC Equine Chorionic Gonadotropin (eCG) for Injection Sales Forecast by Region (2025-2030) & (K Units)
Table 64. APAC Equine Chorionic Gonadotropin (eCG) for Injection Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 65. Europe Equine Chorionic Gonadotropin (eCG) for Injection Sales Forecast by Country (2025-2030) & (K Units)
Table 66. Europe Equine Chorionic Gonadotropin (eCG) for Injection Revenue Forecast by Country (2025-2030) & ($ millions)
Table 67. Middle East & Africa Equine Chorionic Gonadotropin (eCG) for Injection Sales Forecast by Country (2025-2030) & (K Units)
Table 68. Middle East & Africa Equine Chorionic Gonadotropin (eCG) for Injection Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales Forecast by Type (2025-2030) & (K Units)
Table 70. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue Forecast by Type (2025-2030) & ($ millions)
Table 71. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales Forecast by Application (2025-2030) & (K Units)
Table 72. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue Forecast by Application (2025-2030) & ($ millions)
Table 73. MSD Animal Health Basic Information, Equine Chorionic Gonadotropin (eCG) for Injection Manufacturing Base, Sales Area and Its Competitors
Table 74. MSD Animal Health Equine Chorionic Gonadotropin (eCG) for Injection Product Portfolios and Specifications
Table 75. MSD Animal Health Equine Chorionic Gonadotropin (eCG) for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 76. MSD Animal Health Main Business
Table 77. MSD Animal Health Latest Developments
Table 78. Ceva Santй Animale Basic Information, Equine Chorionic Gonadotropin (eCG) for Injection Manufacturing Base, Sales Area and Its Competitors
Table 79. Ceva Santй Animale Equine Chorionic Gonadotropin (eCG) for Injection Product Portfolios and Specifications
Table 80. Ceva Santй Animale Equine Chorionic Gonadotropin (eCG) for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 81. Ceva Santй Animale Main Business
Table 82. Ceva Santй Animale Latest Developments
Table 83. Syntex SA Basic Information, Equine Chorionic Gonadotropin (eCG) for Injection Manufacturing Base, Sales Area and Its Competitors
Table 84. Syntex SA Equine Chorionic Gonadotropin (eCG) for Injection Product Portfolios and Specifications
Table 85. Syntex SA Equine Chorionic Gonadotropin (eCG) for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 86. Syntex SA Main Business
Table 87. Syntex SA Latest Developments
Table 88. Bioveta Basic Information, Equine Chorionic Gonadotropin (eCG) for Injection Manufacturing Base, Sales Area and Its Competitors
Table 89. Bioveta Equine Chorionic Gonadotropin (eCG) for Injection Product Portfolios and Specifications
Table 90. Bioveta Equine Chorionic Gonadotropin (eCG) for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 91. Bioveta Main Business
Table 92. Bioveta Latest Developments
Table 93. Ningbo Sansheng Biological Technology Basic Information, Equine Chorionic Gonadotropin (eCG) for Injection Manufacturing Base, Sales Area and Its Competitors
Table 94. Ningbo Sansheng Biological Technology Equine Chorionic Gonadotropin (eCG) for Injection Product Portfolios and Specifications
Table 95. Ningbo Sansheng Biological Technology Equine Chorionic Gonadotropin (eCG) for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 96. Ningbo Sansheng Biological Technology Main Business
Table 97. Ningbo Sansheng Biological Technology Latest Developments
Table 98. Ningbo Second Hormone Factory Basic Information, Equine Chorionic Gonadotropin (eCG) for Injection Manufacturing Base, Sales Area and Its Competitors
Table 99. Ningbo Second Hormone Factory Equine Chorionic Gonadotropin (eCG) for Injection Product Portfolios and Specifications
Table 100. Ningbo Second Hormone Factory Equine Chorionic Gonadotropin (eCG) for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 101. Ningbo Second Hormone Factory Main Business
Table 102. Ningbo Second Hormone Factory Latest Developments
Table 103. Chifeng Bo-en Pharmaceutical Basic Information, Equine Chorionic Gonadotropin (eCG) for Injection Manufacturing Base, Sales Area and Its Competitors
Table 104. Chifeng Bo-en Pharmaceutical Equine Chorionic Gonadotropin (eCG) for Injection Product Portfolios and Specifications
Table 105. Chifeng Bo-en Pharmaceutical Equine Chorionic Gonadotropin (eCG) for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 106. Chifeng Bo-en Pharmaceutical Main Business
Table 107. Chifeng Bo-en Pharmaceutical Latest Developments
Table 108. Guangzhou Vbio-Pharma Basic Information, Equine Chorionic Gonadotropin (eCG) for Injection Manufacturing Base, Sales Area and Its Competitors
Table 109. Guangzhou Vbio-Pharma Equine Chorionic Gonadotropin (eCG) for Injection Product Portfolios and Specifications
Table 110. Guangzhou Vbio-Pharma Equine Chorionic Gonadotropin (eCG) for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 111. Guangzhou Vbio-Pharma Main Business
Table 112. Guangzhou Vbio-Pharma Latest Developments
Table 113. JALLY Basic Information, Equine Chorionic Gonadotropin (eCG) for Injection Manufacturing Base, Sales Area and Its Competitors
Table 114. JALLY Equine Chorionic Gonadotropin (eCG) for Injection Product Portfolios and Specifications
Table 115. JALLY Equine Chorionic Gonadotropin (eCG) for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 116. JALLY Main Business
Table 117. JALLY Latest Developments
Table 118. Ningbo Creator Animal Pharmaceutical Basic Information, Equine Chorionic Gonadotropin (eCG) for Injection Manufacturing Base, Sales Area and Its Competitors
Table 119. Ningbo Creator Animal Pharmaceutical Equine Chorionic Gonadotropin (eCG) for Injection Product Portfolios and Specifications
Table 120. Ningbo Creator Animal Pharmaceutical Equine Chorionic Gonadotropin (eCG) for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 121. Ningbo Creator Animal Pharmaceutical Main Business
Table 122. Ningbo Creator Animal Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Picture of Equine Chorionic Gonadotropin (eCG) for Injection
Figure 2. Equine Chorionic Gonadotropin (eCG) for Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Equine Chorionic Gonadotropin (eCG) for Injection Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Country/Region (2023)
Figure 10. Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of 1000 IU/Unit
Figure 12. Product Picture of 5000 IU/Unit
Figure 13. Product Picture of Others
Figure 14. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Type in 2023
Figure 15. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue Market Share by Type (2019-2024)
Figure 16. Equine Chorionic Gonadotropin (eCG) for Injection Consumed in Pig
Figure 17. Global Equine Chorionic Gonadotropin (eCG) for Injection Market: Pig (2019-2024) & (K Units)
Figure 18. Equine Chorionic Gonadotropin (eCG) for Injection Consumed in Cattle
Figure 19. Global Equine Chorionic Gonadotropin (eCG) for Injection Market: Cattle (2019-2024) & (K Units)
Figure 20. Equine Chorionic Gonadotropin (eCG) for Injection Consumed in Sheep
Figure 21. Global Equine Chorionic Gonadotropin (eCG) for Injection Market: Sheep (2019-2024) & (K Units)
Figure 22. Equine Chorionic Gonadotropin (eCG) for Injection Consumed in Horse
Figure 23. Global Equine Chorionic Gonadotropin (eCG) for Injection Market: Horse (2019-2024) & (K Units)
Figure 24. Equine Chorionic Gonadotropin (eCG) for Injection Consumed in Other Animals
Figure 25. Global Equine Chorionic Gonadotropin (eCG) for Injection Market: Other Animals (2019-2024) & (K Units)
Figure 26. Global Equine Chorionic Gonadotropin (eCG) for Injection Sale Market Share by Application (2023)
Figure 27. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue Market Share by Application in 2023
Figure 28. Equine Chorionic Gonadotropin (eCG) for Injection Sales by Company in 2023 (K Units)
Figure 29. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Company in 2023
Figure 30. Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Company in 2023 ($ millions)
Figure 31. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue Market Share by Company in 2023
Figure 32. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Geographic Region (2019-2024)
Figure 33. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue Market Share by Geographic Region in 2023
Figure 34. Americas Equine Chorionic Gonadotropin (eCG) for Injection Sales 2019-2024 (K Units)
Figure 35. Americas Equine Chorionic Gonadotropin (eCG) for Injection Revenue 2019-2024 ($ millions)
Figure 36. APAC Equine Chorionic Gonadotropin (eCG) for Injection Sales 2019-2024 (K Units)
Figure 37. APAC Equine Chorionic Gonadotropin (eCG) for Injection Revenue 2019-2024 ($ millions)
Figure 38. Europe Equine Chorionic Gonadotropin (eCG) for Injection Sales 2019-2024 (K Units)
Figure 39. Europe Equine Chorionic Gonadotropin (eCG) for Injection Revenue 2019-2024 ($ millions)
Figure 40. Middle East & Africa Equine Chorionic Gonadotropin (eCG) for Injection Sales 2019-2024 (K Units)
Figure 41. Middle East & Africa Equine Chorionic Gonadotropin (eCG) for Injection Revenue 2019-2024 ($ millions)
Figure 42. Americas Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Country in 2023
Figure 43. Americas Equine Chorionic Gonadotropin (eCG) for Injection Revenue Market Share by Country (2019-2024)
Figure 44. Americas Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Type (2019-2024)
Figure 45. Americas Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Application (2019-2024)
Figure 46. United States Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth 2019-2024 ($ millions)
Figure 47. Canada Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth 2019-2024 ($ millions)
Figure 48. Mexico Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth 2019-2024 ($ millions)
Figure 49. Brazil Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth 2019-2024 ($ millions)
Figure 50. APAC Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Region in 2023
Figure 51. APAC Equine Chorionic Gonadotropin (eCG) for Injection Revenue Market Share by Region (2019-2024)
Figure 52. APAC Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Type (2019-2024)
Figure 53. APAC Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Application (2019-2024)
Figure 54. China Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth 2019-2024 ($ millions)
Figure 55. Japan Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth 2019-2024 ($ millions)
Figure 56. South Korea Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth 2019-2024 ($ millions)
Figure 57. Southeast Asia Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth 2019-2024 ($ millions)
Figure 58. India Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth 2019-2024 ($ millions)
Figure 59. Australia Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth 2019-2024 ($ millions)
Figure 60. China Taiwan Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth 2019-2024 ($ millions)
Figure 61. Europe Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Country in 2023
Figure 62. Europe Equine Chorionic Gonadotropin (eCG) for Injection Revenue Market Share by Country (2019-2024)
Figure 63. Europe Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Type (2019-2024)
Figure 64. Europe Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Application (2019-2024)
Figure 65. Germany Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth 2019-2024 ($ millions)
Figure 66. France Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth 2019-2024 ($ millions)
Figure 67. UK Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth 2019-2024 ($ millions)
Figure 68. Italy Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth 2019-2024 ($ millions)
Figure 69. Russia Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth 2019-2024 ($ millions)
Figure 70. Middle East & Africa Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Country (2019-2024)
Figure 71. Middle East & Africa Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Type (2019-2024)
Figure 72. Middle East & Africa Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Application (2019-2024)
Figure 73. Egypt Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth 2019-2024 ($ millions)
Figure 74. South Africa Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth 2019-2024 ($ millions)
Figure 75. Israel Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth 2019-2024 ($ millions)
Figure 76. Turkey Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth 2019-2024 ($ millions)
Figure 77. GCC Countries Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth 2019-2024 ($ millions)
Figure 78. Manufacturing Cost Structure Analysis of Equine Chorionic Gonadotropin (eCG) for Injection in 2023
Figure 79. Manufacturing Process Analysis of Equine Chorionic Gonadotropin (eCG) for Injection
Figure 80. Industry Chain Structure of Equine Chorionic Gonadotropin (eCG) for Injection
Figure 81. Channels of Distribution
Figure 82. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Forecast by Region (2025-2030)
Figure 83. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue Market Share Forecast by Region (2025-2030)
Figure 84. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share Forecast by Type (2025-2030)
Figure 85. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue Market Share Forecast by Type (2025-2030)
Figure 86. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share Forecast by Application (2025-2030)
Figure 87. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Equine Chorionic Gonadotropin (eCG) for Injection
Figure 2. Equine Chorionic Gonadotropin (eCG) for Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Equine Chorionic Gonadotropin (eCG) for Injection Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Country/Region (2023)
Figure 10. Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of 1000 IU/Unit
Figure 12. Product Picture of 5000 IU/Unit
Figure 13. Product Picture of Others
Figure 14. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Type in 2023
Figure 15. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue Market Share by Type (2019-2024)
Figure 16. Equine Chorionic Gonadotropin (eCG) for Injection Consumed in Pig
Figure 17. Global Equine Chorionic Gonadotropin (eCG) for Injection Market: Pig (2019-2024) & (K Units)
Figure 18. Equine Chorionic Gonadotropin (eCG) for Injection Consumed in Cattle
Figure 19. Global Equine Chorionic Gonadotropin (eCG) for Injection Market: Cattle (2019-2024) & (K Units)
Figure 20. Equine Chorionic Gonadotropin (eCG) for Injection Consumed in Sheep
Figure 21. Global Equine Chorionic Gonadotropin (eCG) for Injection Market: Sheep (2019-2024) & (K Units)
Figure 22. Equine Chorionic Gonadotropin (eCG) for Injection Consumed in Horse
Figure 23. Global Equine Chorionic Gonadotropin (eCG) for Injection Market: Horse (2019-2024) & (K Units)
Figure 24. Equine Chorionic Gonadotropin (eCG) for Injection Consumed in Other Animals
Figure 25. Global Equine Chorionic Gonadotropin (eCG) for Injection Market: Other Animals (2019-2024) & (K Units)
Figure 26. Global Equine Chorionic Gonadotropin (eCG) for Injection Sale Market Share by Application (2023)
Figure 27. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue Market Share by Application in 2023
Figure 28. Equine Chorionic Gonadotropin (eCG) for Injection Sales by Company in 2023 (K Units)
Figure 29. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Company in 2023
Figure 30. Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Company in 2023 ($ millions)
Figure 31. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue Market Share by Company in 2023
Figure 32. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Geographic Region (2019-2024)
Figure 33. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue Market Share by Geographic Region in 2023
Figure 34. Americas Equine Chorionic Gonadotropin (eCG) for Injection Sales 2019-2024 (K Units)
Figure 35. Americas Equine Chorionic Gonadotropin (eCG) for Injection Revenue 2019-2024 ($ millions)
Figure 36. APAC Equine Chorionic Gonadotropin (eCG) for Injection Sales 2019-2024 (K Units)
Figure 37. APAC Equine Chorionic Gonadotropin (eCG) for Injection Revenue 2019-2024 ($ millions)
Figure 38. Europe Equine Chorionic Gonadotropin (eCG) for Injection Sales 2019-2024 (K Units)
Figure 39. Europe Equine Chorionic Gonadotropin (eCG) for Injection Revenue 2019-2024 ($ millions)
Figure 40. Middle East & Africa Equine Chorionic Gonadotropin (eCG) for Injection Sales 2019-2024 (K Units)
Figure 41. Middle East & Africa Equine Chorionic Gonadotropin (eCG) for Injection Revenue 2019-2024 ($ millions)
Figure 42. Americas Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Country in 2023
Figure 43. Americas Equine Chorionic Gonadotropin (eCG) for Injection Revenue Market Share by Country (2019-2024)
Figure 44. Americas Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Type (2019-2024)
Figure 45. Americas Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Application (2019-2024)
Figure 46. United States Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth 2019-2024 ($ millions)
Figure 47. Canada Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth 2019-2024 ($ millions)
Figure 48. Mexico Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth 2019-2024 ($ millions)
Figure 49. Brazil Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth 2019-2024 ($ millions)
Figure 50. APAC Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Region in 2023
Figure 51. APAC Equine Chorionic Gonadotropin (eCG) for Injection Revenue Market Share by Region (2019-2024)
Figure 52. APAC Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Type (2019-2024)
Figure 53. APAC Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Application (2019-2024)
Figure 54. China Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth 2019-2024 ($ millions)
Figure 55. Japan Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth 2019-2024 ($ millions)
Figure 56. South Korea Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth 2019-2024 ($ millions)
Figure 57. Southeast Asia Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth 2019-2024 ($ millions)
Figure 58. India Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth 2019-2024 ($ millions)
Figure 59. Australia Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth 2019-2024 ($ millions)
Figure 60. China Taiwan Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth 2019-2024 ($ millions)
Figure 61. Europe Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Country in 2023
Figure 62. Europe Equine Chorionic Gonadotropin (eCG) for Injection Revenue Market Share by Country (2019-2024)
Figure 63. Europe Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Type (2019-2024)
Figure 64. Europe Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Application (2019-2024)
Figure 65. Germany Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth 2019-2024 ($ millions)
Figure 66. France Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth 2019-2024 ($ millions)
Figure 67. UK Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth 2019-2024 ($ millions)
Figure 68. Italy Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth 2019-2024 ($ millions)
Figure 69. Russia Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth 2019-2024 ($ millions)
Figure 70. Middle East & Africa Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Country (2019-2024)
Figure 71. Middle East & Africa Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Type (2019-2024)
Figure 72. Middle East & Africa Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Application (2019-2024)
Figure 73. Egypt Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth 2019-2024 ($ millions)
Figure 74. South Africa Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth 2019-2024 ($ millions)
Figure 75. Israel Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth 2019-2024 ($ millions)
Figure 76. Turkey Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth 2019-2024 ($ millions)
Figure 77. GCC Countries Equine Chorionic Gonadotropin (eCG) for Injection Revenue Growth 2019-2024 ($ millions)
Figure 78. Manufacturing Cost Structure Analysis of Equine Chorionic Gonadotropin (eCG) for Injection in 2023
Figure 79. Manufacturing Process Analysis of Equine Chorionic Gonadotropin (eCG) for Injection
Figure 80. Industry Chain Structure of Equine Chorionic Gonadotropin (eCG) for Injection
Figure 81. Channels of Distribution
Figure 82. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Forecast by Region (2025-2030)
Figure 83. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue Market Share Forecast by Region (2025-2030)
Figure 84. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share Forecast by Type (2025-2030)
Figure 85. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue Market Share Forecast by Type (2025-2030)
Figure 86. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share Forecast by Application (2025-2030)
Figure 87. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue Market Share Forecast by Application (2025-2030)
